Do children with Bell's palsy benefit from steroid treatment? A systematic review

Jacob Pitaro1, Sofia Waissbluth, Sam J Daniel

  • 1Division of Otolaryngology-Head and Neck Surgery, The Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

Insights

This systematic review found insufficient evidence on steroid treatment for Bell

Area of Science:

  • Pediatric Neurology
  • Otolaryngology
  • Evidence-Based Medicine

Background:

  • Bell's palsy (BP) is a common cause of acute unilateral facial nerve paralysis in children.
  • Steroid therapy is frequently used, but its efficacy in pediatric BP remains debated.

Purpose of the Study:

  • To systematically review the outcomes of steroid treatment for Bell's palsy in children.
  • To assess the current evidence base for corticosteroid efficacy in pediatric BP.

Main Methods:

  • A systematic search of MEDLINE, EMBASE, Cochrane Library, and BIOSIS Previews (2000-2010).
  • Inclusion of studies on children (0-18 years) with BP treated solely with corticosteroids.
  • Analysis of facial movement outcomes using clinical scales; included study designs: RCTs, cohort studies, cross-sectional studies, case series.

Main Results:

  • 6 studies met inclusion criteria from 2293 initially identified papers.
  • Heterogeneous reporting of steroid type and treatment duration.
  • Predominance of retrospective cohort and case-series studies (Level 4 evidence).

Conclusions:

  • No controlled trials were identified for steroid treatment in pediatric Bell's palsy.
  • The current evidence is insufficient to confirm the role of steroids in treating childhood BP.
  • Further high-quality research, including controlled trials, is necessary.
Abstract

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...